Prevalence of switching from two anti-TNF biosimilars back to biologic reference products in Germany 
.

CONCLUSION: Almost one third of the patients treated with one of two biosimilar drugs after previous biologic therapy are switched back to reference products in Germany.
. PMID: 30990409 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research